期刊文献+

循环肿瘤细胞检测技术的研究进展 被引量:7

Current status and future of circulating tumor cell detection
下载PDF
导出
摘要 循环肿瘤细胞(circulating tumor cell,CTC)检测是一种新型的"液体活检"技术,具有无创、便捷、实时、整体、精准和可重复操作等特点,为临床提供了从肿瘤细胞到分子水平的分析平台,弥补了现有临床肿瘤诊断方法的不足,有助于实现肿瘤患者的精准医疗。本文主要就CTC检测技术的临床应用价值和常用方法等最新进展作一综述。 The detection of circulating tumor cells is a new type of " liquid biopsy" technique. It has the advantages of non-invasiveness,convenience,real-time,integrity,precision and repeatability.The technique provides a clinical analysis platform from cellular to molecular levels,and makes up the deficiency of the existing methods of cancer diagnosis,to facilitate more accurate medical treatment for cancer patients. This article reviews the latest progress on the clinical application and common methods of circulating tumor cell detection.
作者 黄子凌 宇小婷 易祥华 HUANG Zi-ling;YU Xiao-ting;YI Xiang-hua(Dept.of Pathology,Tongji Hospital,Tongji University,Shanghai 200065,China)
出处 《同济大学学报(医学版)》 CAS 2018年第3期123-127,共5页 Journal of Tongji University(Medical Science)
基金 国家自然科学基金(81600043 81401882) 上海市科学技术委员会医学重点科技攻关专项基金(09411951600) 上海市卫生局医学重点专项基金(20134034)
关键词 循环肿瘤细胞 病理技术 精准医学 circulating tumor cells pathological technique precision medicine
  • 相关文献

参考文献1

二级参考文献17

  • 1邓水秋,欧阳学农,余宗阳,房文铮,王文武,刘志臻.晚期非小细胞肺癌血清游离DNA水平变化及意义[J].山东医药,2013,53(30):6-8. 被引量:4
  • 2张弦,唐立.非小细胞肺癌患者血中DNA片段的检测、定量及临床意义的研究[J].中国微生态学杂志,2007,19(6):516-518. 被引量:5
  • 3Vasioukhin V, Anker P, Maurice P, et al. Point mutation of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia[ J ]. Br J Haematol, 1994,86 (4) : 774 - 779.
  • 4Sorenson GD, Pribish DM, Valone FH, et al. Soluble normal and mutated DNA sequences from single-copy genes in human blood [ J ]. Cancer Epidemiol Biomarkers Prev, 1994,3 : 67 - 71.
  • 5Jung K, Fleischhacker M, Rabien A. Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature [ J ]. Clin Chim Acta, 2010, 411(21 -22) : 1611 - 1624.
  • 6Shapiro B, Chakrabarty M, Clhn EM, et al. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease [ J]. Cancer, 1983,51 ( 11 ) ,2116 - 2120.
  • 7. Szpechcinski A, Chorostowska-Wynimko J, Struniawski R, et al. Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease[J]. Br J Cancer, 2015,113(3) : 476-483.
  • 8Ludovini V, Pistola L, Gregorc V, et al. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology [J]. J Thorac Oncol, 2008,3(4) : 365 -373.
  • 9Sozzi G, Conte D, Mariani L, et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients [ J ]. Cancer Res, 2001,61 (12) : 4675 -4678.
  • 10Jylhivi J, Kotipelto T, Raitala A, et al. Aging is associated with quantitative and qualitative changes in circulating cell-free DNA: the Vitality 90 + study [ J ]. Mech Ageing Dev, 2011,132(1 -2) : 20-26.

共引文献2

同被引文献79

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部